胰岛素输注装置市场规模、份额和成长分析（按产品类型、糖尿病类型、最终用户和地区划分）－2026-2033年产业预测

全球胰岛素输送设备市场规模预计在 2024 年达到 180.2 亿美元，从 2025 年的 194.4 亿美元成长到 2033 年的 357.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.9%。

全球胰岛素输注设备市场正经历强劲成长，主要驱动力是全球糖尿病患者数量的不断增加。这种需求的激增推动了更先进、更便利的糖尿病管理系统的发展。数位技术的整合有望进一步促进市场扩张，尤其是透过持续血糖监测（CGM）系统等创新技术。 CGM系统使胰岛素输注设备能够根据持续的血糖值测量值即时自动调整剂量。此外，可穿戴式和贴片式胰岛素帮浦因其隐蔽性和便利性而备受关注。包括贴片式胰岛素系统极具前景的新应用在内的技术进步，代表着胰岛素输注方式在满足患者需求方面的能力和有效性的显着提升。

推动全球胰岛素输注设备市场发展的因素

全球胰岛素输注设备市场正经历显着成长，这得益于一个可互通生态系统的兴起，该生态系统将胰岛素输注系统与持续血糖监测仪 (CGM)、智慧型手机应用程式、智慧胰岛素笔和连网胰岛素帮浦整合在一起。这种互联互通提高了给药精度，增强了患者的依从性，并支持医护人员进行远端监测，从而减少了低血糖事件和就诊次数。随着远距远端医疗服务和数位化糖尿病管理计画的报销范围不断扩大，越来越多的连网设备被应用于居家照护和门诊治疗。这一趋势不仅增强了医护人员的信心，也提高了病患的舒适度和糖尿病管理的参与度。

全球胰岛素输送装置市场限制因素

全球胰岛素输注设备市场，尤其是自动胰岛素帮浦和整合系统市场，面临设备及其耗材高成本的巨大挑战，这在价格敏感的市场中构成了一大障碍。地区报销政策的差异进一步加剧了这一困境，而有限的保险覆盖范围也往往降低了产品的普及率。此外，许多支付方不愿核准贴片帮浦和闭合迴路系统等先进技术，阻碍了市场渗透。为了改善病患用药途径并降低成本，製造商必须证明其产品在医疗环境中的合法性和可行性。

全球胰岛素输注装置市场趋势

紧凑型无导管贴片式胰岛素帮浦的普及是全球胰岛素输注设备市场的一大趋势，它将胰岛素注射转变为更便利、更人性化的体验。这些创新设备摒弃了繁琐的导管，同时整合了先进的智慧型手机控制和自动化演算法，从而提升了用户的舒适度和依从性。这项技术革新不仅吸引了现有用户，也吸引了那些对传统胰岛素帮浦犹豫不决的患者。随着医疗专业人员不断评估并推荐这些系统，以期改善患者的治疗效果，预计此类设备的需求将大幅增长，这反映出人们正朝着更高效的糖尿病管理解决方案转变。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

全球胰岛素输注装置市场规模（依产品类型及复合年增长率划分）（2026-2033 年）

• 胰岛素笔
• 胰岛素帮浦（有线）
• 胰岛素帮浦（无导管/贴片式）
• 胰岛素注射器和针头
• 智慧型胰岛素输送装置

全球胰岛素输注装置市场规模（依糖尿病类型划分）及复合年增长率（2026-2033 年）

• 1型糖尿病
• 2型糖尿病
• 妊娠糖尿病
• 其他特殊患者群

全球胰岛素输注设备市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 居家照护/自我管理
• 医院和诊所
• 专业糖尿病照护中心

全球胰岛素注射装置市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Medtronic plc
• Insulet Corporation
• Novo Nordisk A/S
• Sanofi
• Eli Lilly and Company
• Ypsomed AG
• B. Braun SE
• Owen Mumford Ltd.
• BD（Becton, Dickinson and Company）
• Tandem Diabetes Care, Inc.
• Roche Holding AG（Diabetes Care Division）
• Abbott Laboratories（Diabetes Care）
• Johnson & Johnson（Diabetes Solutions）
• Dexcom, Inc.（Integrated pump solutions）
• Ascensia Diabetes Care Holdings AG
• SOOIL Development Co., Ltd.
• Nippon Boehringer Ingelheim Co., Ltd.
• Terumo Corporation
• AgaMatrix
• Omron Healthcare Co., Ltd.

结论与建议

Global Insulin Delivery Devices Market size was valued at USD 18.02 Billion in 2024 and is poised to grow from USD 19.44 Billion in 2025 to USD 35.72 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The global market for insulin delivery devices is experiencing robust growth, primarily fueled by the rising prevalence of diabetes worldwide. This surge in demand is leading to the development of more advanced, user-friendly diabetes management systems. The integration of digital technologies is expected to further propel market expansion, particularly through innovations like Continuous Glucose Monitoring (CGM) systems, which enable insulin delivery devices to automatically adjust dosages in real-time based on continuous glucose readings. Additionally, wearable and patch insulin pumps are gaining traction as discreet and convenient solutions for insulin administration. The advancement of technologies, including promising new applications for patch insulin systems, signifies a significant evolution in the capabilities and effectiveness of insulin delivery methods, catering to the needs of patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Delivery Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Delivery Devices Market Segments Analysis

Global Insulin Delivery Devices Market is segmented by Product Type, Diabetes Type, End-User and region. Based on Product Type, the market is segmented into Insulin Pens, Insulin Pumps (Tethered), Insulin Pumps (Tubeless / Patch), Insulin Syringes & Needles and Smart Insulin Delivery Devices. Based on Diabetes Type, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other Special Populations. Based on End-User, the market is segmented into Home Care / Self-administration, Hospitals & Clinics and Specialized Diabetes Care Centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market is experiencing significant growth due to the rise of interoperable ecosystems that integrate insulin delivery systems with continuous glucose monitors (CGMs), smartphone applications, smart pens, and connected pumps. This connectivity enhances dosage precision, fosters patient adherence, and enables remote monitoring by healthcare providers, which can lead to a reduction in hypoglycemic events and decreased hospital visits. As reimbursement for telehealth services and digital diabetes management programs continues to expand, more connected devices are being introduced into home care and outpatient settings. This trend not only boosts clinician confidence but also increases patient comfort and engagement in their diabetes management.

Restraints in the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market faces significant challenges due to the elevated costs associated with these devices and their necessary consumables, especially for automated pumps and integrated systems, which creates barriers for price-sensitive markets. Variations in reimbursement mechanisms across regions further complicate the situation, often leading to decreased adoption when coverage is limited. Moreover, many payers exhibit hesitance in endorsing advanced technologies such as patch pumps and closed-loop systems, which hinders their market penetration. To enhance accessibility and reduce expenses for patients, manufacturers must demonstrate that their products are justifiable and attainable within the healthcare landscape.

Market Trends of the Global Insulin Delivery Devices Market

The Global Insulin Delivery Devices market is witnessing a notable trend towards the adoption of smaller, tubeless patch pumps, which are transforming insulin administration into a more convenient and user-friendly experience. These innovative devices are designed to enhance user comfort and compliance by eliminating cumbersome tubing while integrating advanced smartphone controls and automated algorithms. This technological evolution is appealing not only to existing users but also to those who have been hesitant to embrace traditional insulin pumps. As healthcare professionals continue to endorse these systems for their potential to improve patient outcomes, the demand for such devices is anticipated to surge, reflecting a broader shift towards more efficient diabetes management solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Insulin Delivery Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Insulin Pens
• Insulin Pumps (Tethered)
• Insulin Pumps (Tubeless / Patch)
• Insulin Syringes & Needles
• Smart Insulin Delivery Devices

Global Insulin Delivery Devices Market Size by Diabetes Type & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Other Special Populations

Global Insulin Delivery Devices Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Home Care / Self-administration
• Hospitals & Clinics
• Specialized Diabetes Care Centres

Global Insulin Delivery Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Diabetes Type, End-User)
  • US
  • Canada
• Europe (Product Type, Diabetes Type, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Diabetes Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Diabetes Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Diabetes Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Diabetes Care Division)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (Diabetes Care)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (Diabetes Solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (Integrated pump solutions)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SOOIL Development Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nippon Boehringer Ingelheim Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations